Preprint · CC-BY
via OpenAlex
Is There a Hereditary Cancer Resistance Genotype?
Qeios · 2026
Abstract
Most of the knowledge about germline related cancer risks emerged from pioneering studies of families with increased cancer incidence. This led to the discovery of the chapter of hereditary cancer predisposing syndromes. More than 50 syndromes have been identified and thoroughly studied. While most germline studies focused on pathogenic variants that increase cancer risk (e.g. BRCA1/2, CHEK2 with ORs up to 8.6), little research has been dedicated to the opposite situation, that is germline mutations or variants that decrease the risk of cancer. The methods employed in these cancer risk reduction studies were not centered on family history of cancer but rather on genome wide association studies (GWAS). A body of knowledge has been accumulating in this regard slowly but steadily. The aim of this review is to summarize the main genetic features that can reduce the risk of develop cancer in general and in some specific cancers as well.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.32388/dcrtzv
- Canonical
- link ↗
- Fetched
- 2026-10-27 MST
Cite this
APA
Koltai, T. (2026). Is There a Hereditary Cancer Resistance Genotype?. <em>Qeios</em>. https://doi.org/10.32388/dcrtzv
Vancouver
Koltai T. Is There a Hereditary Cancer Resistance Genotype?. Qeios. 2026. doi:10.32388/dcrtzv.
BibTeX
@unpublished{tomas2026IsTher,
title = {Is There a Hereditary Cancer Resistance Genotype?},
author = {Tomas Koltai},
journal = {Qeios},
year = {2026},
doi = {10.32388/dcrtzv},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
InTech eBooks 2012
Open access · OA
Therapeutic Exploitation of Targeting Programmed Cell Death for Cervical Cancer
BIBSYS Brage (BIBSYS (Norway)) 2016
Preprint · CC-BY
Calorie and protein restriction in mammals : a review and comparison on respect to aging
npj Precision Oncology 2019
Open access · CC-BY
Accumulation of genetic and epigenetic alterations in normal cells and cancer risk
Signal transduction and targeted therapy 2026
Open access · OA
Aging and cancer: current understandings and future perspectives.
Frontiers in Oncology 2017
Open access · CC-BY
A Trickster in Disguise: Hyaluronan’s Ambivalent Roles in the Matrix
PLoS Genetics 2006
Open access · CC-BY